iRay Technology Past Earnings Performance
Past criteria checks 2/6
iRay Technology has been growing earnings at an average annual rate of 27.1%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 24.8% per year. iRay Technology's return on equity is 12.2%, and it has net margins of 31%.
Key information
27.1%
Earnings growth rate
23.4%
EPS growth rate
Medical Equipment Industry Growth | 16.0% |
Revenue growth rate | 24.8% |
Return on equity | 12.2% |
Net Margin | 31.0% |
Next Earnings Update | 26 Apr 2025 |
Recent past performance updates
Recent updates
Is iRay Technology (SHSE:688301) A Risky Investment?
Nov 18iRay Technology Company Limited (SHSE:688301) Soars 25% But It's A Story Of Risk Vs Reward
Sep 28iRay Technology (SHSE:688301) Might Be Having Difficulty Using Its Capital Effectively
Sep 27iRay Technology's (SHSE:688301) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 26iRay Technology Company Limited Just Missed EPS By 12%: Here's What Analysts Think Will Happen Next
Apr 23Are iRay Technology Company Limited (SHSE:688301) Investors Paying Above The Intrinsic Value?
Apr 11Slowing Rates Of Return At iRay Technology (SHSE:688301) Leave Little Room For Excitement
Mar 21With iRay Technology Company Limited (SHSE:688301) It Looks Like You'll Get What You Pay For
Feb 28Revenue & Expenses Breakdown
How iRay Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 1,823 | 565 | 233 | 325 |
30 Jun 24 | 1,933 | 590 | 225 | 293 |
31 Mar 24 | 1,914 | 610 | 205 | 272 |
31 Dec 23 | 1,864 | 607 | 203 | 261 |
30 Sep 23 | 1,842 | 566 | 191 | 259 |
30 Jun 23 | 1,786 | 689 | 185 | 255 |
31 Mar 23 | 1,663 | 677 | 185 | 244 |
31 Dec 22 | 1,549 | 641 | 163 | 239 |
30 Sep 22 | 1,468 | 666 | 144 | 218 |
30 Jun 22 | 1,352 | 551 | 131 | 196 |
31 Mar 22 | 1,291 | 510 | 116 | 174 |
31 Dec 21 | 1,187 | 484 | 124 | 146 |
30 Sep 21 | 1,054 | 392 | 92 | 119 |
30 Jun 21 | 955 | 322 | 86 | 106 |
31 Mar 21 | 872 | 265 | 76 | 99 |
31 Dec 20 | 784 | 222 | 66 | 94 |
30 Sep 20 | 787 | 218 | 80 | 92 |
30 Jun 20 | 730 | 180 | 85 | 88 |
31 Mar 20 | 581 | 116 | 85 | 86 |
31 Dec 19 | 546 | 96 | 87 | 86 |
31 Dec 18 | 439 | 61 | 85 | 67 |
31 Dec 17 | 356 | 54 | 71 | 47 |
31 Dec 16 | 256 | 43 | 84 | 0 |
31 Dec 15 | 213 | 19 | 89 | 0 |
Quality Earnings: 688301 has a high level of non-cash earnings.
Growing Profit Margin: 688301's current net profit margins (31%) are higher than last year (30.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688301's earnings have grown significantly by 27.1% per year over the past 5 years.
Accelerating Growth: 688301's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 688301 had negative earnings growth (-0.3%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 688301's Return on Equity (12.2%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/29 04:15 |
End of Day Share Price | 2024/12/27 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
iRay Technology Company Limited is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jiongyi Hu | China International Capital Corporation Limited |
Shuo Song | Citic Securities Co., Ltd. |
Zhu Chen | Citic Securities Co., Ltd. |